240 related articles for article (PubMed ID: 22982073)
1. Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin.
Liu W; Feng Q; Li Y; Ye L; Hu M; Liu Z
Toxicol Appl Pharmacol; 2012 Dec; 265(3):316-24. PubMed ID: 22982073
[TBL] [Abstract][Full Text] [Related]
2. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model.
Jeong EJ; Lin H; Hu M
J Pharmacol Exp Ther; 2004 Jul; 310(1):376-85. PubMed ID: 15020665
[TBL] [Abstract][Full Text] [Related]
3. Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.
Qin Z; Li S; Yao Z; Hong X; Wu B; Krausz KW; Gonzalez FJ; Gao H; Yao X
Food Funct; 2018 Mar; 9(3):1410-1423. PubMed ID: 29318243
[TBL] [Abstract][Full Text] [Related]
4. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
[TBL] [Abstract][Full Text] [Related]
6. UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.
Jiang W; Xu B; Wu B; Yu R; Hu M
Drug Metab Dispos; 2012 Feb; 40(2):336-45. PubMed ID: 22071170
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic study on the intestinal absorption and disposition of baicalein.
Zhang L; Lin G; Kovács B; Jani M; Krajcsi P; Zuo Z
Eur J Pharm Sci; 2007 Jul; 31(3-4):221-31. PubMed ID: 17507208
[TBL] [Abstract][Full Text] [Related]
8. Stable knock-down of efflux transporters leads to reduced glucuronidation in UGT1A1-overexpressing HeLa cells: the evidence for glucuronidation-transport interplay.
Zhang X; Dong D; Wang H; Ma Z; Wang Y; Wu B
Mol Pharm; 2015 Apr; 12(4):1268-78. PubMed ID: 25741749
[TBL] [Abstract][Full Text] [Related]
9. The pharmaceutical excipient PEG400 affect the absorption of baicalein in Caco-2 monolayer model by interacting with UDP-glucuronosyltransferases and efflux transport proteins.
Cao S; Zhang M; Yuan M; Yang D; Zhao M; Zhang S; Wang P; Zhang R; Gao X
Pharmacol Res Perspect; 2022 Feb; 10(1):e00928. PubMed ID: 35148019
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model.
Hu M; Chen J; Lin H
J Pharmacol Exp Ther; 2003 Oct; 307(1):314-21. PubMed ID: 12893842
[TBL] [Abstract][Full Text] [Related]
11. Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters.
Yang J; Zhang B; Qin Z; Li S; Xu J; Yao Z; Zhang X; Gonzalez FJ; Yao X
Biofactors; 2018 Nov; 44(6):558-569. PubMed ID: 30334318
[TBL] [Abstract][Full Text] [Related]
12. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells.
Prime-Chapman HM; Fearn RA; Cooper AE; Moore V; Hirst BH
J Pharmacol Exp Ther; 2004 Nov; 311(2):476-84. PubMed ID: 15210835
[TBL] [Abstract][Full Text] [Related]
13. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2.
Akao T; Hanada M; Sakashita Y; Sato K; Morita M; Imanaka T
J Pharm Pharmacol; 2007 Jan; 59(1):87-93. PubMed ID: 17227625
[TBL] [Abstract][Full Text] [Related]
14. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.
Ming X; Knight BM; Thakker DR
Mol Pharm; 2011 Oct; 8(5):1677-86. PubMed ID: 21780830
[TBL] [Abstract][Full Text] [Related]
15. Characterization of chrysin glucuronidation in UGT1A1-overexpressing HeLa cells: elucidating the transporters responsible for efflux of glucuronide.
Quan E; Wang H; Dong D; Zhang X; Wu B
Drug Metab Dispos; 2015 Apr; 43(4):433-43. PubMed ID: 25595598
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1.
Zhang B; Yang J; Qin Z; Li S; Xu J; Yao Z; Zhang X; Gonzalez FJ; Yao X
PLoS One; 2019; 14(5):e0217695. PubMed ID: 31150474
[TBL] [Abstract][Full Text] [Related]
17. Interplay of Efflux Transporters with Glucuronidation and Its Impact on Subcellular Aglycone and Glucuronide Disposition: A Case Study with Kaempferol.
Li Y; Lu L; Wang L; Qu W; Liu W; Xie Y; Zheng H; Wang Y; Qi X; Hu M; Zhu L; Liu Z
Mol Pharm; 2018 Dec; 15(12):5602-5614. PubMed ID: 30376625
[TBL] [Abstract][Full Text] [Related]
18. Glyceollin Effects on MRP2 and BCRP in Caco-2 Cells, and Implications for Metabolic and Transport Interactions.
Chimezie C; Ewing A; Schexnayder C; Bratton M; Glotser E; Skripnikova E; Sá P; Boué S; Stratford RE
J Pharm Sci; 2016 Feb; 105(2):972-981. PubMed ID: 26296158
[TBL] [Abstract][Full Text] [Related]
19. Site-specific bidirectional efflux of 2,4-dinitrophenyl-S-glutathione, a substrate of multidrug resistance-associated proteins, in rat intestine and Caco-2 cells.
Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
J Pharm Pharmacol; 2007 Apr; 59(4):513-20. PubMed ID: 17430634
[TBL] [Abstract][Full Text] [Related]
20. Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
Oswald S; Haenisch S; Fricke C; Sudhop T; Remmler C; Giessmann T; Jedlitschky G; Adam U; Dazert E; Warzok R; Wacke W; Cascorbi I; Kroemer HK; Weitschies W; von Bergmann K; Siegmund W
Clin Pharmacol Ther; 2006 Mar; 79(3):206-17. PubMed ID: 16513445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
